Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease
Abstract
Objectives: To determine the annual rates of volumetric change of the hippocampus and temporal horn in cognitively normal elderly control subjects and individually matched patients with AD, and to test the hypothesis that these rates were different.
Background: Cross-sectional studies consistently reveal cerebral atrophy in elderly nondemented subjects compared with healthy young adults, and greater atrophy in patients with AD relative to elderly control subjects. However, rates of atrophy are estimated most accurately by performing serial measurements in the same individuals.
Methods: MRI-based volumetric measurements of the hippocampi and temporal horns were performed in 24 cognitively normal subjects aged 70 to 89 years who were individually matched with respect to gender and age with 24 patients with AD. Each subject underwent an MRI protocol twice, separated by 12 months or more.
Results: The mean annual rate of hippocampal volume loss among control subjects was -1.55 ± 1.38% and the temporal horns increased in volume by 6.15 ± 7.69% per year. These rates were significantly greater among AD patients: hippocampus, -3.98 ± 1.92% per year, p < 0.001; temporal horn, 14.16 ± 8.47% per year, p = 0.002.
Conclusion: A statistically significant yearly decline in hippocampal volume and an increase in temporal horn volume was identified in elderly control subjects who represent typical aging individuals. These rates were approximately 2.5 times greater in patients with AD than in individually age- and gender-matched control subjects.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Convit A, de Leon MJ, Golomb J, et al. Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatr Q 1993;64:371-387.
2.
DeCarli C, Kaye JA, Horwitz B, Rapoport SI. Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type. Neurology 1990;40:872-883.
3.
DeCarli C, Murphy DGM, Gillette JA, et al. Lack of age-related differences in temporal lobe volume of very healthy adults. AJNR Am J Neuroradiol 1994;15:689-696.
4.
Jack CR Jr, Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
5.
Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-54.
6.
de Leon MJ, George AE, Stylopoulos LA, et al. Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet 1989;2:672-673.
7.
Killiany RJ, Moss MB, Albert MS, et al. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993;50:949-954.
8.
Laakso MP, Soininen H, Partanen K, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm 1995;9:73-86.
9.
Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 1994;15:927-937.
10.
Murphy DGM, DeCarli C, Schapiro MB, et al. Age-related differences in volumes of subcortical nuclei, brain matter, and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging. Arch Neurol 1992;49:839-845.
11.
Pearlson GD, Harris GJ, Powers RE, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992;49:402-408.
12.
Soininen HS, Partanen K, Pitkanen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994;44:1660-1668.
13.
Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
14.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
15.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Revised 3rd ed. Washington, DC: American Psychiatric Association, 1987.
16.
Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
17.
Tsai MS, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994;54:643-649.
18.
Jack CR Jr. MRI-based hippocampal volume measurements in epilepsy. Epilepsia 1994;35(suppl 6):S21-S29.
19.
Jack CR Jr, Gehring D, Sharbrough F, et al. Temporal lobe volume measurement from MR images: accuracy and left-right asymmetry in normal individuals. J Comput Assist Tomogr 1988;12(1):21-29.
20.
Elias MF, Wolf PA, D'Agostini RB, et al. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993;138:353-364.
21.
Launer LJ, Masaki K, Petrovitch H, et al. The association between midlife blood pressure levels and late-life cognitive function. JAMA 1995;274:1846-1851.
22.
Davis PJM, Wright EA. A new method for measuring cranial cavity volume and its application to the assessment of cerebral atrophy at autopsy. Neuropathol Appl Neurobiol 1977;3:341-358.
23.
Miller AKH, Alston RL, Corsellis JAN. Variation with age in the volumes of grey and white matter in the cerebral hemispheres spheres of man: measurements with an image analyser. Neuropathol Appl Neurobiol 1980;6:119-132.
24.
Pakkenberg H, Voight F. Brain weight of the Danes. Acta Anat (Basel) 1964;56:297-307.
25.
Peress NS, Kane WC, Aronson SM. Central nervous system findings in a tenth decade autopsy population. In: Ford DH, ed. Progress in brain research. Elsevier: Amsterdam, 1973.
26.
Pfefferbaum A, Mathalon DH, Sullivan EV, et al. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 1994;51:874-887.
27.
George AE, deLeon MJ, Rosenbloom S, et al. Ventricular volume and cognitive deficit: a computed tomographic study. Radiology 1983;149:493-498.
28.
Kaye JA, DeCarli C, Luxenberg JS, Rapoport SI. The significance of age-related enlargement of the cerebral ventricles in healthy men and women measured by quantitative computed x-ray tomography. J Am Geriatr Soc 1992;40:225-231.
29.
Gur RC, Mozley PD, Resnick SM, et al. Gender differences in age effect on brain atrophy measured by magnetic resonance imaging. Proc Natl Acad Sci USA 1991;88:2845-2849.
30.
Coffey CE, Wilkinson WE, Parashos IA, et al. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology 1992;42:527-536.
31.
Blatter DD, Bigler ED, Gale SD, et al. Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. AJNR Am J Neuroradiol 1995;16:241-251.
32.
Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A. Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol Aging 1995;16:591-606.
33.
Kaye JA, Swihart T, Howieson D, Dame A. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997;48:1297-1304.
34.
Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794.
35.
DeCarli C, Murphy DGM, Tranh M, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995;45:2077-2084.
36.
Salerno JA, Murphy DGM, Horwitz B, et al. Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. Hypertension 1992;20:340-348.
37.
Jobst KA, Smith AD, Szatmari M, et al. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet 1994;343:829-830.
38.
Fox MC, Warrington EK, Freeborough PA. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 1996;119:2001-2007.
39.
DeCarli C, Haxby JV, Gillette JA, et al. Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology 1993;42:2029-2036.
40.
Wippold FJ, Gado MH, Morris JC, et al. Senile dementia and healthy aging: a longitudinal CT study. Radiology 1992;179:215-219.
41.
Growdon J, Locasio J, Corkin S, et al. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996;47:444-448.
42.
Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol 1996;39:62-70.
Information & Authors
Information
Published In
Copyright
© 1998.
Publication History
Published online: October 1, 1998
Published in print: October 1998
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Effect of chemotherapy on hippocampal volume and shape in older long-term breast cancer survivors, Frontiers in Aging Neuroscience, 16, (2024).https://doi.org/10.3389/fnagi.2024.1347721
- Revised Temperament and Character Inventory factors predict neuropsychiatric symptoms and aging-related cognitive decline across 25 years, Frontiers in Aging Neuroscience, 16, (2024).https://doi.org/10.3389/fnagi.2024.1335336
- Orienteering combines vigorous-intensity exercise with navigation to improve human cognition and increase brain-derived neurotrophic factor, PLOS ONE, 19, 5, (e0303785), (2024).https://doi.org/10.1371/journal.pone.0303785
- Inverse relationship between platelet Akt activity and hippocampal atrophy: A pilot case-control study in patients with diabetes mellitus, World Journal of Clinical Cases, 12, 2, (302-313), (2024).https://doi.org/10.12998/wjcc.v12.i2.302
- Free-water: A promising structural biomarker for cognitive decline in aging and mild cognitive impairment, Imaging Neuroscience, 2, (1-16), (2024).https://doi.org/10.1162/imag_a_00293
- Automated detection of Alzheimer’s disease: a multi-modal approach with 3D MRI and amyloid PET, Scientific Reports, 14, 1, (2024).https://doi.org/10.1038/s41598-024-56001-9
- The role of the human hippocampus in decision-making under uncertainty, Nature Human Behaviour, 8, 7, (1366-1382), (2024).https://doi.org/10.1038/s41562-024-01855-2
- A multi-site study on sex differences in cortical thickness in non-demented Parkinson’s disease, npj Parkinson's Disease, 10, 1, (2024).https://doi.org/10.1038/s41531-024-00686-2
- CCADD: An online webserver for Alzheimer's disease detection from brain MRI, Computers in Biology and Medicine, 177, (108622), (2024).https://doi.org/10.1016/j.compbiomed.2024.108622
- The role of dynapenia and obesity on cognitive function in older adults, Clinical Nutrition ESPEN, 63, (191-196), (2024).https://doi.org/10.1016/j.clnesp.2024.06.039
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.